| DOCK1 — Dedicator of Cytokinesis 1 Protein | |
|---|---|
| Protein Name | Dedicator of Cytokinesis 1 Protein |
| Gene | DOCK1 |
| UniProt ID | Q8IU85 |
| PDB IDs | 1WP6, 5E34, 5E35 |
| Molecular Weight | 215 kDa (1,864 amino acids) |
| Subcellular Localization | Cytoplasm, Plasma membrane, Lamellipodia |
| Protein Family | DOCK family (DOCK-A subfamily) |
| Brain Expression | High in hippocampus, cortex, cerebellum |
DOCK1 (Dedicator of Cytokinesis 1) is a large guanine nucleotide exchange factor (GEF) that specifically activates Rac GTPases through its DHR-2 (Docker Homology Region 2) domain[1]. As one of the largest members of the DOCK family (DOCK1-11), DOCK1 plays critical roles in actin cytoskeleton reorganization, cell migration, phagocytosis, and membrane ruffling[2]. In the nervous system, DOCK1 is essential for neuronal development, dendritic spine formation, synaptic plasticity, and has been implicated in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[3].
DOCK1 has a distinctive modular structure:
Multiple DOCK1 isoforms exist through alternative splicing:
| Modification | Site | Functional Effect |
|---|---|---|
| Phosphorylation | Tyr722, Tyr1731 | GEF activity regulation |
| Acetylation | Lys816 | Protein stability |
| Ubiquitination | Lys1823 | Degradation |
DOCK1 regulates critical cellular processes:
In neurons, DOCK1 plays essential roles[4]:
DOCK1 shows region-specific expression in the brain:
DOCK1 dysregulation contributes to AD pathogenesis[5]:
Studies show elevated DOCK1 expression in AD brain tissue, particularly in regions with high amyloid plaque burden.
In PD, DOCK1 affects dopaminergic neuron survival[6]:
DOCK1 contributes to motor neuron degeneration in ALS[7]:
In HD, DOCK1 dysfunction affects striatal neuron survival[8]:
Growth Factor → Receptor Tyrosine Kinase
↓
DOCK1 (GEF activation)
↓
Rac1-GTP → WAVE Complex → Arp2/3 → Actin Polymerization
↓
Lamellipodia, Membrane Ruffling, Cell Migration
| Partner | Interaction Type | Functional Consequence |
|---|---|---|
| Rac1 | GEF substrate | Actin polymerization |
| WAVE2 | Effector | Actin nucleation |
| Elmo1 | Adapter | Phagocytosis |
| Crk | Adapter | Signaling scaffold |
| Grb2 | Adapter | Growth factor signaling |
DOCK1 is a potential therapeutic target:
Cote JF et al., DOCK1, a dedicator of cytokinesis (2005). Molecular Biology of the Cell. ↩︎
Fukui Y et al., DOCK family GEFs in cell migration (2012). Nature Reviews Molecular Cell Biology. ↩︎
Kawabe H et al., DOCK proteins in neuronal development (2019). Nature Reviews Neuroscience. ↩︎
Xiang J et al., DOCK1 in dendritic spine formation (2019). PNAS. ↩︎
Zhang Y et al., DOCK1 in Alzheimer's disease (2020). Journal of Neuroscience. ↩︎
Kim J et al., DOCK1 in Parkinson's disease (2021). Molecular Neurobiology. ↩︎
Chen L et al., DOCK1 in ALS pathogenesis (2022). Neurobiology of Disease. ↩︎
Li M et al., DOCK1 in Huntington's disease (2021). Journal of Cellular Physiology. ↩︎